Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha-thalassaemia.

L F Bernini1, C L Harteveld

  • 1Institute of Human Genetics, Medical Faculty, University of Leiden, Sylvius Laboratory, The Netherlands.

Bailliere'S Clinical Haematology
|June 29, 2000
PubMed
Summary

Alpha-thalassemias are genetic blood disorders caused by reduced alpha-globin production. Diagnosis involves molecular techniques like PCR to identify deletions and mutations, crucial for understanding disease phenotypes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Moderate-severe beta-thalassemia intermedia phenotype caused by sextuplicated alpha-globin gene allele in two beta-thalassemia carriers.

American journal of hematology·2024
Same author

Suppression of Hb Bart's to improve tissue oxygenation and fetal development in homozygous alpha-thalassemia.

American journal of hematology·2024
Same author

A novel α<sup>0</sup>-thalassemia deletion in a Brazilian child with Hb H disease: --<sup>Mococa</sup>.

International journal of laboratory hematology·2024
Same author

Molecular analysis of complex cases of alpha- and beta-thalassemia in Mexican mestizo patients with microcytosis and hypochromia reveals two novel alpha(0) -thalassemia deletions - -(Mex1) and - -(Mex2).

International journal of laboratory hematology·2016
Same author

Sickle cell anemia and α-thalassemia: a modulating factor in homozygous HbS/S patients in Oman.

European journal of medical genetics·2014
Same author

Aberrant glycated haemoglobin (HbA1c) results leading to haemoglobinopathy diagnosis in four Belgian patients.

Acta clinica Belgica·2014

Area of Science:

  • Genetics
  • Molecular Biology
  • Hematology

Background:

  • Alpha-thalassemias are common genetic defects impacting alpha-globin production.
  • These defects arise from point mutations or deletions within the alpha-globin gene cluster on chromosome 16.
  • The severity ranges from silent carriers to lethal hydrops fetalis.

Purpose of the Study:

  • To review the genetic basis of alpha-thalassemias.
  • To describe the molecular mechanisms underlying alpha-thalassemia.
  • To outline the diagnostic approaches and clinical phenotypes.

Main Methods:

  • Analysis of DNA deletions and point mutations using Southern blotting and PCR-based strategies.
  • Identification of mutations via DGGE, SSCP, and direct sequencing.
  • Study of regulatory elements like HS-40 and transacting factors (e.g., ATR-X syndrome).

Main Results:

  • Deletions are more frequent than point mutations, ranging from single gene loss to entire cluster deletion.
  • Mutations can affect mRNA processing, polypeptide stability, or gene expression via regulatory regions.
  • Specific deletions can lead to contiguous gene syndromes like ATR-16.
  • Acquired alpha-thalassemia and ATR-X syndrome involve complex regulatory mechanisms.

Conclusions:

  • Alpha-thalassemia presents diverse phenotypes based on the genetic defect.
  • Molecular diagnostics, particularly PCR, are essential for accurate identification and classification.
  • Understanding gene regulation is key to explaining complex cases and associated syndromes.

Related Experiment Videos